TTK Healthcare Limited (TTKHLTCARE) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of TTK Healthcare Limited stock ₹517, price ₹938, that is 44.9% below the price, quality 48 out of 100. Rating: strongly overvalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
TTK Healthcare Limited
TTKHLTCARE · NSEFar too expensive (fair value 45% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
60‑month range ₹612.02 – ₹1,811 · fair‑value band ₹468.95 – ₹536.39 · the ₹938.45 price screens above the ₹516.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether TTK Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments.
Show moreShow less
The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents.
The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners.
The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements.
The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products.
The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name.
The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
Stock analysis
TTK Healthcare Limited (TTKHLTCARE) currently trades at ₹938.45, while our model-based Fair Value estimate is ₹516.73, 45% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹939.08 per share, and 4 of the 17 models we run sit above the ₹938.45 price.
Bear case: the Dividend Discount group reads lowest at ₹99.84, and 13 of the 17 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹468.95 (bear) to ₹536.39 (bull), the price of ₹938.45 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
TTK Healthcare Limited reported revenue of ₹8.6B in FY2026 versus ₹6.0B in FY2022, a compound +9.4%/yr. Reported net income was ₹657M in FY2026, compounding +12.1%/yr from FY2022.
Key figures
Market cap ₹13.3B (≈ $141M) Micro · P/E ratio 17.9 · P/S ratio 1.49 · EPS (TTM) ₹52.34 · Dividend yield 1.1% · Net margin 8.3% · Return on equity 6.0% · Return on assets (EBIT) 8.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 28% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −45%, TTKHLTCARE screens richer than that median.
Fair Value models
All 17 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
TTKHLTCARE screens overvalued: fair value 45% below the price. Compare with Eli Lilly and Company →
Compare TTK Healthcare Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 73 stocks
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Bristol-Myers Squibb Company BMY | $63.43 | $75.91 | +20% | vs TTKHLTCARE |
| Amgen Inc AMGN | $465.67 | $512.24 | +10% | vs TTKHLTCARE |
| Gilead Sciences, Inc GILD | $168.08 | $184.89 | +10% | vs TTKHLTCARE |
| Novartis AG NOVN | CHF 134.06 | CHF 122.91 | −8% | vs TTKHLTCARE |
| AbbVie Inc ABBV | $295.03 | $259.62 | −12% | vs TTKHLTCARE |
| Merck & Co MRK | $147.76 | $129.26 | −13% | vs TTKHLTCARE |
| Pfizer Inc PFE | $28.89 | $24.87 | −14% | vs TTKHLTCARE |
| Roche Holding RO | CHF 412.00 | CHF 326.56 | −21% | vs TTKHLTCARE |
| Johnson & Johnson, JNJ | $285.75 | $169.03 | −41% | vs TTKHLTCARE |
| Eli Lilly and Company LLY | $1,444 | $749.92 | −48% | vs TTKHLTCARE |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is TTK Healthcare Limited (TTKHLTCARE) overvalued or undervalued?
What is the fair value of TTKHLTCARE?
What is the quality score of TTKHLTCARE?
What is the price target for TTK Healthcare Limited (TTKHLTCARE)?
What is the TTK Healthcare Limited stock forecast for 2026?
What is the revenue of TTK Healthcare Limited (TTKHLTCARE)?
Does TTK Healthcare Limited pay a dividend?
How much is the dividend of TTK Healthcare Limited (TTKHLTCARE) and when is the ex-dividend date?
What is the intrinsic value of TTK Healthcare Limited (TTKHLTCARE)?
Is TTK Healthcare Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of TTKHLTCARE?
How much is TTK Healthcare Limited worth?
What do the bullish and bearish scenarios say about TTKHLTCARE?
What is the P/E ratio of TTKHLTCARE?
How solid is the balance sheet of TTK Healthcare Limited (TTKHLTCARE)?
How far is TTKHLTCARE from its 52-week high?
Which stocks are comparable to TTK Healthcare Limited?
Is TTK Healthcare Limited stock attractive at the current price?
How is the fair value of TTKHLTCARE calculated?
Is it still worth investing in stocks now?
What is the share price of TTK Healthcare Limited (TTKHLTCARE)?
What should I pay attention to with TTK Healthcare Limited right now?
Where does the earnings growth of TTK Healthcare Limited (TTKHLTCARE) come from?
Key figures of TTK Healthcare Limited
How large is the market capitalisation of TTK Healthcare Limited (TTKHLTCARE)?
What is the P/S ratio of TTK Healthcare Limited (TTKHLTCARE)?
What are the earnings per share of TTK Healthcare Limited (TTKHLTCARE)?
What is the dividend yield of TTK Healthcare Limited (TTKHLTCARE)?
What is the net margin of TTK Healthcare Limited (TTKHLTCARE)?
What is the return on equity of TTK Healthcare Limited (TTKHLTCARE)?
What is the EBIT return on assets of TTK Healthcare Limited (TTKHLTCARE)?
What is the operating margin of TTK Healthcare Limited (TTKHLTCARE)?
How fast is revenue growing at TTK Healthcare Limited (TTKHLTCARE)?
How fast are earnings growing at TTK Healthcare Limited (TTKHLTCARE)?
How much free cash flow does TTK Healthcare Limited (TTKHLTCARE) generate?
How much net debt does TTK Healthcare Limited (TTKHLTCARE) carry?
Watch TTK Healthcare Limited in the live analysis
One click puts TTK Healthcare Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.